Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Abroad (travel likely)Recruiting

Conditions

Lung Cancer · Immune Checkpoint Inhibitor · Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Jianguo Sun

    Principal Investigator

    Department of Oncology, Xinqiao Hospital, Army Medical University